Skip to content

ACHIEVE LIFE SCIENCES, INC.

ACHV · XNAS

CIK 949858fmd_01SPE47R2V4BQSZDFWRHHHGTE9Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading